search
Back to results

High Intensity Intervallic Training in Children With Bronchiolitis Obliterans (PIBOHIIT)

Primary Purpose

Bronchiolitis Obliterans

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Exercise group
Sponsored by
Universitat Internacional de Catalunya
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Bronchiolitis Obliterans focused on measuring High intensity interval training, Post-infectious bronchiolitis obliterans, Telematic program, Cardiorespiratory fitness

Eligibility Criteria

6 Years - 20 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Diagnosis of Postinfectious bronchiolitis obliterans; Clinical stability at the time of the assessments; Age between 6 and 20 years old. Exclusion Criteria: Symptoms of pulmonary exacerbation during the last four weeks; Diagnosis of other cardiorespiratory diseases leading to symptoms of persistent respiratory dysfunction; Difficulty in comprehension or musculoskeletal alterations that may influence the assessments; Pregnancy; Transplant list inclusion.

Sites / Locations

  • Hospital Universitari Vall d'HebronRecruiting
  • Hospital Universitario DonostiaRecruiting
  • Hospital Universitario Infantil Niño JesúsRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Exercise group

Control group

Arm Description

16 weeks of a "High Intensity Interval Training" exercise program conducted telematically with real time supervision twice a week. The exercise program consists of a circuit of exercises aiming to achieve a target heart rate for each fitness level.

Routine physician recommendations for physical activity.

Outcomes

Primary Outcome Measures

Change in peak oxygen consumption
Change in peak oxygen consumption (mL/kg/min) will be evaluated through cardiopulmonary exercise testing (CPET).
Change in time to ventilatory threshold
Change in time to ventilatory threshold (minutes) will be evaluated through cardiopulmonary exercise testing (CPET).
Change in percent oxygen consumption at ventilatory threshold
Change in percent oxygen consumption at ventilatory threshold will be evaluated through cardiopulmonary exercise testing (CPET).
Change in ventilatory efficiency
Change in ventilatory efficiency will be evaluated by combining ventilation (VE) and carbon dioxide production (VCO2) measurements to report VE/VCO2 ratio, evaluated through cardiopulmonary exercise testing (CPET).

Secondary Outcome Measures

Change in forced expiratory volume in the first second
Change in forced expiratory volume in the first second (liters) will be evaluated through spirometry.
Change in forced vital capacity
Change in forced vital capacity (liters) will be evaluated through spirometry.
Change in forced expiratory flow between 25 and 75% of forced vital capacity
Change in forced expiratory flow between 25 and 75% of forced vital capacity (liters/minute) will be evaluated through spirometry.
Change in muscle strength
Changes in muscle strength will be evaluated using a dynamometer.
Change in lower body strength
Changes in lower body strength will be evaluated using the 30 seconds Sit to Stand Test (30STS).
Change in free fat mass
Changes in free fat mass (percent) will be evaluated through bioimpedance.
Change in lean mass
Changes in lean mass (percent) will be evaluated through bioimpedance.
Change in hip-waist ratio
Changes in hip-waist ratio will be evaluated by combining hip circumference and waist circumference measurements using a non-stretchable tape measure.
Change in body mass index
Changes in body mass index will be evaluated by combining weight and height measurements to report BMI (kg/m^2).
Change in quality of life
Changes in quality of life will be evaluated through the Saint George's Respiratory Questionnaire (SRQ). The overall result of the scale is a numerical value from 0 to 100, with the highest values corresponding to a worse quality of life.
Change in dyspnea
Changes in dyspnea will be evaluated through the Medical Research Council (mMRC) modified dyspnea scale. The overall result of the scale is a numerical value from 0 to 4, where the highest value corresponds to the worse dyspnea.

Full Information

First Posted
April 24, 2023
Last Updated
August 3, 2023
Sponsor
Universitat Internacional de Catalunya
Collaborators
Consejo Superior de Deportes
search

1. Study Identification

Unique Protocol Identification Number
NCT05881538
Brief Title
High Intensity Intervallic Training in Children With Bronchiolitis Obliterans
Acronym
PIBOHIIT
Official Title
Effectiveness of a High-intensity Intervallic Training Program in Children and Adolescents With Post-infectious Bronchiolitis Obliterans: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 29, 2023 (Actual)
Primary Completion Date
July 2024 (Anticipated)
Study Completion Date
September 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universitat Internacional de Catalunya
Collaborators
Consejo Superior de Deportes

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Post-Infectious Bronchiolitis Obliterans (PIBO) is an irreversible obstructive lung disease characterized by subepithelial inflammation and fibrotic narrowing of the bronchioles after lower respiratory tract infection. This disease is diagnosed mainly in children, more frequently before the age of 2 years. Due to symptoms such as dry cough and dyspnea sensation, most of these patients have low levels of physical activity compared to healthy individuals. Physical activity can positively influence oxygen consumption, muscle strength, and quality of life. High levels of oxygen consumption are associated with a lower risk of respiratory disease and hospitalization. High-intensity interval training (HIIT) may be an effective way to improve oxygen consumption, muscle strength, and quality of life in patients with chronic diseases. HIIT has been shown to produce less dyspnea sensation and to be more entertaining in children and adolescents with respiratory disease compared to continuous training. Thus, the investigators propose to perform telematically real-time guided training to reduce travel times and additional costs to patients. Objective: To analyze the effects of a telematically supervised high-intensity intervallic training program on aerobic fitness, as well as functional/clinical outcomes in patients with PIBO. Methods: Randomized controlled trial with two groups. Exercise group: 16-week HIIT training conducted telematically; Control group: will follow the routine physician's recommendations. Patients will be recruited at both Vall D'Hebrón University Hospital (Barcelona) and Niño Jesús University Hospital (Madrid). Criteria for participation: (I) Diagnosis of PIBO; (II) Clinically stable at the time of the assessments; (III) Age between 6 to 20 years old.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bronchiolitis Obliterans
Keywords
High intensity interval training, Post-infectious bronchiolitis obliterans, Telematic program, Cardiorespiratory fitness

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Multicenter study, randomized controlled trial in two parallel groups (ratio 1:1), double blinded.
Masking
Care ProviderOutcomes Assessor
Masking Description
The evaluators and care providers will be masked to the allocation of the patients. Given the nature of the intervention, it is not possible to mask patients or monitors in charge of supervising the execution of the exercise training.
Allocation
Randomized
Enrollment
62 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Exercise group
Arm Type
Experimental
Arm Description
16 weeks of a "High Intensity Interval Training" exercise program conducted telematically with real time supervision twice a week. The exercise program consists of a circuit of exercises aiming to achieve a target heart rate for each fitness level.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Routine physician recommendations for physical activity.
Intervention Type
Other
Intervention Name(s)
Exercise group
Other Intervention Name(s)
High Intensity Interval Training
Intervention Description
Participants will perform a 16-week High Intensity Interval Training exercise program, twice a week. The intervention will be conducted telematically with real time supervision.
Primary Outcome Measure Information:
Title
Change in peak oxygen consumption
Description
Change in peak oxygen consumption (mL/kg/min) will be evaluated through cardiopulmonary exercise testing (CPET).
Time Frame
Change from baseline to 16 weeks
Title
Change in time to ventilatory threshold
Description
Change in time to ventilatory threshold (minutes) will be evaluated through cardiopulmonary exercise testing (CPET).
Time Frame
Change from baseline to 16 weeks
Title
Change in percent oxygen consumption at ventilatory threshold
Description
Change in percent oxygen consumption at ventilatory threshold will be evaluated through cardiopulmonary exercise testing (CPET).
Time Frame
Change from baseline to 16 weeks
Title
Change in ventilatory efficiency
Description
Change in ventilatory efficiency will be evaluated by combining ventilation (VE) and carbon dioxide production (VCO2) measurements to report VE/VCO2 ratio, evaluated through cardiopulmonary exercise testing (CPET).
Time Frame
Change from baseline to 16 weeks
Secondary Outcome Measure Information:
Title
Change in forced expiratory volume in the first second
Description
Change in forced expiratory volume in the first second (liters) will be evaluated through spirometry.
Time Frame
Change from baseline to 16 weeks
Title
Change in forced vital capacity
Description
Change in forced vital capacity (liters) will be evaluated through spirometry.
Time Frame
Change from baseline to 16 weeks
Title
Change in forced expiratory flow between 25 and 75% of forced vital capacity
Description
Change in forced expiratory flow between 25 and 75% of forced vital capacity (liters/minute) will be evaluated through spirometry.
Time Frame
Change from baseline to 16 weeks
Title
Change in muscle strength
Description
Changes in muscle strength will be evaluated using a dynamometer.
Time Frame
Change from baseline to 16 weeks
Title
Change in lower body strength
Description
Changes in lower body strength will be evaluated using the 30 seconds Sit to Stand Test (30STS).
Time Frame
Change from baseline to 16 weeks
Title
Change in free fat mass
Description
Changes in free fat mass (percent) will be evaluated through bioimpedance.
Time Frame
Change from baseline to 16 weeks
Title
Change in lean mass
Description
Changes in lean mass (percent) will be evaluated through bioimpedance.
Time Frame
Change from baseline to 16 weeks
Title
Change in hip-waist ratio
Description
Changes in hip-waist ratio will be evaluated by combining hip circumference and waist circumference measurements using a non-stretchable tape measure.
Time Frame
Change from baseline to 16 weeks
Title
Change in body mass index
Description
Changes in body mass index will be evaluated by combining weight and height measurements to report BMI (kg/m^2).
Time Frame
Change from baseline to 16 weeks
Title
Change in quality of life
Description
Changes in quality of life will be evaluated through the Saint George's Respiratory Questionnaire (SRQ). The overall result of the scale is a numerical value from 0 to 100, with the highest values corresponding to a worse quality of life.
Time Frame
Change from baseline to 16 weeks
Title
Change in dyspnea
Description
Changes in dyspnea will be evaluated through the Medical Research Council (mMRC) modified dyspnea scale. The overall result of the scale is a numerical value from 0 to 4, where the highest value corresponds to the worse dyspnea.
Time Frame
Change from baseline to 16 weeks
Other Pre-specified Outcome Measures:
Title
Height in meters
Description
Height will be evaluated using a stadiometer.
Time Frame
Change from baseline to 16 weeks
Title
Weight in kilograms
Description
Weight will be evaluated using a weight scale.
Time Frame
Change from baseline to 16 weeks
Title
Daily physical activity level
Description
Daily physical activity level will be evaluated through the physical activity questionnaire (PAQ). The overall test score is from 1 to 5 points, with a higher score indicating a higher level of activity.
Time Frame
Change from baseline to 16 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of Postinfectious bronchiolitis obliterans; Clinical stability at the time of the assessments; Age between 6 and 20 years old. Exclusion Criteria: Symptoms of pulmonary exacerbation during the last four weeks; Diagnosis of other cardiorespiratory diseases leading to symptoms of persistent respiratory dysfunction; Difficulty in comprehension or musculoskeletal alterations that may influence the assessments; Pregnancy; Transplant list inclusion.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Márcio VF Donadio, PhD
Phone
+34 93 504 20 00
Ext
5370
Email
mdonadio@uic.es
First Name & Middle Initial & Last Name or Official Title & Degree
Inès de Mir Messa, MD PhD
Phone
934 89 30 00
Ext
57
Email
ines.mir@vallhebron.cat
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Márcio VF Donadio, PhD
Organizational Affiliation
Universitat Internacional de Catalunya
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Universitari Vall d'Hebron
City
Barcelona
State/Province
Catalunya
ZIP/Postal Code
08035
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Inès de Mir, PhD
Facility Name
Hospital Universitario Donostia
City
San Sebastián
State/Province
País Vasco
ZIP/Postal Code
20014
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Olaia Sardon Prado, PhD
Facility Name
Hospital Universitario Infantil Niño Jesús
City
Madrid
ZIP/Postal Code
28009
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Verónica Sanz Santiago, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The investigators will collect patients' personal data and clinical history by means of the information delivered by the participating hospital. These data will be stored and coded in an Excel file in order to protect confidentiality before, during and after the study. All information will be entered and stored electronically in the institutional platform REDCAP hosted on the hospitals' server.
IPD Sharing Time Frame
After completion of study, the data will be stored for as long as necessary to meet any possible responsibilities derived from the study.
IPD Sharing Access Criteria
Access will be given only to the researchers of the study.

Learn more about this trial

High Intensity Intervallic Training in Children With Bronchiolitis Obliterans

We'll reach out to this number within 24 hrs